Randomized Trial Supports Long-Term Safety of Proton-Pump Inhibitors

Previously reported excess risks for serious adverse events were not apparent, except for enteric infection.

Source link

Related posts

Incidence of Venous Thromboembolism in Patients with Newly Diagnosed Pancreatic Cancer and Factors Associated With Outcomes


The association between low glucose-6-phosphate dehydrogenase activity level and hepatitis B virus infection among pre-pregnant reproductive-age Chinese females


An Unusual Gastrointestinal Cause of Hypokalemia


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World